Merck’s Mevacor Switch Bid Digs Deeper Into Consumers’ Self-Selection
This article was originally published in The Tan Sheet
Executive Summary
Merck's self-selection study developed to support its latest Mevacor OTC switch application will bolster its bid by providing deeper insight into consumers' selection decisions, the firm says
You may also be interested in...
FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking
A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.
FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking
A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.
FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking
A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.